Evaluation of the Safety, Efficacy, and Pharmacokinetics of SKY0402 in Subjects Undergoing Inguinal Hernia Repair
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to determine the appropriate dose of SKY0402 for the
management of postoperative pain following inguinal hernia repair. This study evaluated the
safety, efficacy, and pharmacokinetics of SKY0402 compared with a 100 mg dose of bupivacaine
HCl for the treatment of postoperative pain in subjects undergoing inguinal hernia repair.
Study drug was administered by surgical wound infiltration at the end of the hernia repair
procedure.